You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
27 February 2026 - Gemma Biotherapeutics (GEMMABio), a US-based clinical-stage global genetic medicines company, announced on Thursday that it has dosed its first parent in the Phase 1/2 CHARISMA clinical trial of GB221, an investigational, next-gene...
26 February 2026 - Biotechnology company Circio Holding ASA (OSE:CRNA) on Thursday reported new in vivo data showing that its AAV-circVec 4.0 platform achieved up to 50-fold higher gene expression in the eye versus conventional mRNA-based AAV followi...
26 February 2026 - Melodia Therapeutics AG, a clinical-stage biotechnology company based in Switzerland, announced on Wednesday that the United States Patent and Trademark Office (USPTO) has granted a key a key patent covering a structurally novel DP...
26 February 2026 - Argo Biopharmaceutical Co Ltd, a China-based, clinical-stage small interfering RNA (siRNA) therapeutics company, announced on Wednesday that it has been selected as a late breaking abstract to present Phase II interim data for BW-2...
25 February 2026 - Dermatology company Galderma (SIX: GALD) disclosed on Wednesday that it has received regulatory approval in the EU, US and Canada for a next-generation syringe for its NASHA lidocaine range of Restylane injectable aesthetic product...
25 February 2026 - Biopharmaceutical company GSK plc (LSE: GSK) (NYSE: GSK) revealed on Wednesday that it has agreed to acquire 35Pharma Inc., a Canada-based clinical-stage biopharmaceutical company, for USD950m in cash, expanding its respiratory and...